Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 105,684 | 122,424 | 104,685 | 102,604 | 91,313 |
| Cost of Goods | 29,732 | 31,904 | 22,304 | 25,201 | 27,303 |
| Gross Profit | 75,952 | 90,520 | 82,381 | 77,403 | 64,010 |
| Operating Expenses | 59,590 | 89,711 | 80,272 | 72,329 | 63,234 |
| Operating Income | 17,094 | 1,713 | 2,413 | 5,275 | 1,079 |
| Interest Expense | 6,022 | 5,996 | 5,940 | 5,878 | 5,814 |
| Other Income | -2,515 | 742 | -2,289 | 1,730 | 2,217 |
| Pre-tax Income | 8,557 | -3,541 | -5,816 | 1,127 | -2,518 |
| Income Tax | 398 | 1,347 | 271 | -1,603 | 253 |
| Net Income Continuous | 8,159 | -4,888 | -6,087 | 2,730 | -2,771 |
| Net Income | $8,159 | $-4,888 | $-6,087 | $2,730 | $-2,771 |
| EPS Basic Total Ops | 0.19 | -0.12 | -0.15 | 0.07 | -0.07 |
| EPS Basic Continuous Ops | 0.19 | -0.12 | -0.15 | 0.07 | -0.07 |
| EPS Diluted Total Ops | 0.19 | -0.11 | -0.15 | 0.06 | -0.07 |
| EPS Diluted Continuous Ops | 0.19 | -0.12 | -0.15 | 0.06 | -0.07 |
| EBITDA(a) | $25,948 | $10,767 | $11,914 | $14,384 | $8,444 |